InvestorsHub Logo
Followers 89
Posts 18057
Boards Moderated 0
Alias Born 09/06/2006

Re: dstock07734 post# 705169

Wednesday, 07/10/2024 5:11:33 PM

Wednesday, July 10, 2024 5:11:33 PM

Post# of 730858
Every inventor assigns their rights separately. All versions of the combo patent are presently assigned to all 4 of NWBO, Revimune, CRL and NIH.

What that means is all 4 can use the invention (which s the idea of treating a GBM patient with both an ATL-DC and a CI). And all 4 can license it,

The NIH does not matter. It is standard for University work done under a NIH grant to be assigned back to them, but they rarely (if ever) use it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News